Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.650
+0.050 (3.12%)
At close: Jun 26, 2026, 4:00 PM EDT
1.601
-0.049 (-2.95%)
After-hours: Jun 26, 2026, 7:41 PM EDT
PACB Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for PACB stock have an average target of 2.38, with a low estimate of 1.50 and a high estimate of 3.00. The average target predicts an increase of 44.24% from the current stock price of 1.65.
Analyst Consensus: Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for PACB stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Reiterates $1 → $1.5 | Sell | Reiterates | $1 → $1.5 | -9.09% | May 11, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $3 | Buy | Reiterates | $3 | +81.82% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 | Hold | Reiterates | $2 | +21.21% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $3 | Buy | Reiterates | $3 | +81.82% | May 8, 2026 |
| Guggenheim | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 12, 2026 |
Financial Forecast
Revenue This Year
167.82M
from 160.01M
Increased by 4.88%
Revenue Next Year
193.83M
from 167.82M
Increased by 15.50%
EPS This Year
-0.51
from -0.53
EPS Next Year
-0.40
from -0.51
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 171.0M | 198.3M | |
| Avg | 167.8M | 193.8M | |
| Low | 165.0M | 189.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.9% | 18.2% | |
| Avg | 4.9% | 15.5% | |
| Low | 3.1% | 12.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.49 | -0.23 | |
| Avg | -0.51 | -0.40 | |
| Low | -0.52 | -0.48 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.